Clinical Cardiac Electrophysiology Cardiology Division Department of Medicine Hospital São Paulo Escola Paulista de Medicina - Universidade Federal of São Paulo São Paulo Brazil.
J Am Heart Assoc. 2022 Jan 4;11(1):e021889. doi: 10.1161/JAHA.121.021889. Epub 2021 Dec 20.
Background Ventricular tachycardia (VT) in patients with chronic chagasic cardiomyopathy (CCC) is associated with considerable morbidity and mortality. Catheter ablation of VT in patients with CCC is very complex and challenging. The main goal of this work was to assess the efficacy of VT catheter ablation guided by late potentials (LPs) in patients with CCC. Methods and Results Seventeen consecutive patients with refractory VT and CCC were prospectively included in the study. Combined endo-epicardial voltage and late activation mapping were obtained during baseline rhythm to define scarred and LP areas, respectively. The end point of the ablation procedure was the elimination of all identified LPs. Epicardial and endocardial dense scars (<0.5 mV) were detected in 17/17 and 15/17 patients, respectively. LPs were detected in the epicardial scars of 16/17 patients and in the endocardial scars of 14/15 patients. A total of 63 VTs were induced in 17 patients; 22/63 (33%) were stable and entrained, presenting LPs recorded in the isthmus sites. The end point of ablation was achieved in 15 of 17 patients. Ablation was not completed in 2 patients because of cardiac tamponade or vicinity of the phrenic nerve and circumflex artery. Three patients (2 with unsuccessful ablation) had VT recurrence during follow-up (39 months). Conclusions Endo-epicardial LP mapping allows us to identify the putative isthmuses of different VTs and effectively perform catheter ablation in patients with CCC and drug-refractory VTs.
慢性恰加斯病性心肌病(CCC)患者的室性心动过速(VT)与相当大的发病率和死亡率相关。对 CCC 患者 VT 的导管消融非常复杂和具有挑战性。这项工作的主要目的是评估 LP 引导的 CCC 患者 VT 导管消融的疗效。
17 例难治性 VT 合并 CCC 的连续患者前瞻性纳入研究。在基础节律期间获得心内膜-心外膜电压和晚期激活标测,以分别定义瘢痕和 LP 区域。消融程序的终点是消除所有确定的 LP。17/17 例患者检测到心外膜和心内膜密集瘢痕(<0.5 mV),15/17 例患者检测到心内膜瘢痕。在 17 例患者中诱发 63 次 VT;22/63(33%)为稳定和程控,记录到峡部部位的 LP。15/17 例患者达到消融终点。2 例患者因心脏压塞或膈神经和回旋支动脉附近而未完成消融。3 例(2 例消融不成功)患者在随访期间(39 个月)出现 VT 复发。
心内膜-心外膜 LP 标测可用于识别不同 VT 的可能峡部,并有效对 CCC 患者和药物难治性 VT 进行导管消融。